TI
TALPHERA, INC.
SEC filingPharmaceuticals · San Mateo, CA
Amount raised$17Msold at filing
Total offering$29M$12M still open
Investors in the raise13count reported to the SEC
FiledSep 15, 2025first sale Sep 10, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Adrian P AdamsDirector
Shakil P AslamExecutive Officer
Abhinav J JainDirector
Vincent J AngottiExecutive Officer, Director
Marina P BozilenkoDirector
Raffi P AsadorianExecutive Officer
Mark J WanDirector
Jill P BroadfootDirector
Stephen J HoffmanDirector
Badri P DasuExecutive Officer
Executive officers, directors and promoters as listed on the Form D.